EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

During the COVID-19 health emergency, two strategies for detecting coronavirus infections were commonly adopted around the world. Part of Nature Outlook: Medical diagnostics Initially, in countries ...

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

Rite Aid is joining forces with Quest Diagnostics to provide access to molecular testing (polymerase chain reaction or similar nucleic acid amplification test) to help Rite Aid customers detect and ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

GREENWICH — How many people are getting their noses swabbed at COVID-19 testing sites anymore? Not many. Greenwich Hospital is conducting approximately 70 percent less molecular COVID-19 tests than it ...

Point-of-care testing for common sexually transmitted infections may reduce overuse of antibiotics and improve emergency ...

WORCESTER – Anyone who gets a negative result for COVID-19 from an at-home rapid antigen test shouldn't assume they're not infected, and should keep testing, according to a safety recommendation ...